Lumexa Imaging(NASDAQ) LMRI

Lumexa Imaging helps people get medical pictures of their bodies. These scans help doctors find health problems and plan treatments. The company runs many centers for X-rays and medical scans.

What Services are Provided?

• Advanced Imaging: High-tech scans like magnetic resonance imaging (MRI) and computed tomography (CT); accounts for 52% of consolidated revenue for the year ended December 31, 2025.
• Routine Imaging: Standard services like X-rays, ultrasounds, and mammography used for regular health screenings and basic medical diagnostics.
• Professional Services: Detailed readings and interpretations of medical images provided by specialized doctors known as radiologists.
• Remote Care: Teleradiology services through the Connexia platform which allow doctors to read and analyze patient scans from any location.

Building a National Network

• Completed an initial public offering (IPO) of 25 million shares in 2025, raising approximately $427 million in net proceeds.
• Expanded the footprint to 188 centers across 13 states by late 2025 through 21 acquisitions and 44 newly built locations.
• Formed eight joint venture partnerships with major health systems including Baylor Scott & White Health and Atrium Health to share resources.
• Launched Connexia in 2023 to build internal remote-reading capabilities and reduce reliance on third-party radiology groups.

Why the Platform Stands Out

Lumexa Imaging operates the second largest outpatient imaging network in the United States, focusing on urban areas with high population growth. The company uses third-party artificial intelligence tools to improve scan speeds and automate administrative tasks like scheduling and patient billing.

By the Numbers

• Consolidated revenue hit $1.023 billion for the year ended December 31, 2025, up 7.8% from 2024.
• Revenue reached $267.7 million in Q4 2025, up 7.9% from the same period in 2024.
• Gross profit was $29.7 million in Q4 2025, up 37.8% from $21.6 million in Q4 2024.
• Operating income fell to -$7.5 million in Q4 2025, worsened from $15.3 million in Q4 2024.
• Net loss hit -$28.7 million for the quarter ended December 31, 2025, worsened from a $25.1 million loss in Q4 2024.

The Bottom Line

Lumexa Imaging has evolved from a small regional operator into a large national platform through aggressive acquisitions and new center development. Its focus on advanced imaging technology and partnerships with health systems supports its position in the growing outpatient medical market.